Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON30974Not yet recruiting
Open-label trial of prilocaine (2 arms), sponsored by OLVG. Primary endpoints: Foetomaternal distribution of prilocaine, Newborn methemoglobin levels after maternal prilocaine perineal block and 1 more. Planned start May 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON30974.